State of Alaska Department of Revenue Sells 1,590 Shares of Waters Co. (NYSE:WAT)

State of Alaska Department of Revenue lessened its holdings in Waters Co. (NYSE:WATFree Report) by 12.3% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,385 shares of the medical instruments supplier’s stock after selling 1,590 shares during the quarter. State of Alaska Department of Revenue’s holdings in Waters were worth $3,918,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently bought and sold shares of WAT. IMPACTfolio LLC grew its position in Waters by 4.2% during the fourth quarter. IMPACTfolio LLC now owns 803 shares of the medical instruments supplier’s stock valued at $264,000 after buying an additional 32 shares during the period. Mountain Pacific Investment Advisers Inc. ID boosted its stake in Waters by 0.3% in the fourth quarter. Mountain Pacific Investment Advisers Inc. ID now owns 11,469 shares of the medical instruments supplier’s stock valued at $3,776,000 after acquiring an additional 34 shares during the last quarter. Hohimer Wealth Management LLC grew its position in shares of Waters by 2.7% during the 4th quarter. Hohimer Wealth Management LLC now owns 1,354 shares of the medical instruments supplier’s stock valued at $446,000 after acquiring an additional 35 shares during the period. Armstrong Henry H Associates Inc. increased its stake in shares of Waters by 0.4% during the 1st quarter. Armstrong Henry H Associates Inc. now owns 10,819 shares of the medical instruments supplier’s stock worth $3,724,000 after purchasing an additional 40 shares during the last quarter. Finally, Czech National Bank raised its holdings in shares of Waters by 0.5% in the 1st quarter. Czech National Bank now owns 10,403 shares of the medical instruments supplier’s stock worth $3,581,000 after purchasing an additional 48 shares during the period. Institutional investors own 94.01% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have issued reports on WAT shares. Barclays decreased their target price on Waters from $295.00 to $275.00 and set an “underweight” rating for the company in a research report on Friday, June 28th. Jefferies Financial Group began coverage on Waters in a research note on Monday, June 3rd. They issued a “hold” rating and a $320.00 price objective on the stock. Robert W. Baird cut their target price on shares of Waters from $319.00 to $312.00 and set a “neutral” rating for the company in a research report on Wednesday, May 8th. Evercore ISI lowered their price target on shares of Waters from $320.00 to $300.00 and set an “in-line” rating on the stock in a research report on Tuesday. Finally, TD Cowen raised their price objective on shares of Waters from $350.00 to $358.00 and gave the stock a “hold” rating in a report on Wednesday, May 8th. One research analyst has rated the stock with a sell rating and eleven have assigned a hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $301.20.

Get Our Latest Research Report on WAT

Waters Stock Up 1.1 %

Shares of NYSE WAT opened at $287.50 on Friday. Waters Co. has a 12 month low of $231.90 and a 12 month high of $367.21. The company has a current ratio of 1.94, a quick ratio of 1.30 and a debt-to-equity ratio of 1.60. The firm has a market capitalization of $17.05 billion, a price-to-earnings ratio of 28.21, a PEG ratio of 4.58 and a beta of 0.95. The business has a 50-day moving average of $314.81 and a 200-day moving average of $323.09.

Waters (NYSE:WATGet Free Report) last issued its quarterly earnings data on Tuesday, May 7th. The medical instruments supplier reported $2.21 EPS for the quarter, topping the consensus estimate of $2.10 by $0.11. Waters had a return on equity of 66.59% and a net margin of 20.75%. The company had revenue of $636.80 million during the quarter, compared to analyst estimates of $635.57 million. During the same quarter in the previous year, the firm earned $2.49 earnings per share. Waters’s revenue was down 7.0% on a year-over-year basis. Sell-side analysts expect that Waters Co. will post 11.85 earnings per share for the current fiscal year.

Insider Transactions at Waters

In other Waters news, Director Richard H. Fearon acquired 1,000 shares of the business’s stock in a transaction dated Tuesday, May 28th. The stock was bought at an average price of $332.90 per share, with a total value of $332,900.00. Following the completion of the acquisition, the director now owns 1,653 shares of the company’s stock, valued at $550,283.70. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other Waters news, Director Christopher A. Kuebler sold 4,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 15th. The stock was sold at an average price of $361.64, for a total value of $1,446,560.00. Following the completion of the sale, the director now owns 14,716 shares of the company’s stock, valued at $5,321,894.24. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Richard H. Fearon bought 1,000 shares of the business’s stock in a transaction on Tuesday, May 28th. The stock was purchased at an average cost of $332.90 per share, with a total value of $332,900.00. Following the purchase, the director now owns 1,653 shares of the company’s stock, valued at $550,283.70. The disclosure for this purchase can be found here. 0.82% of the stock is owned by insiders.

Waters Company Profile

(Free Report)

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Featured Articles

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.